Report overview
Platelet-rich plasma (PRP) is a biological therapy that uses the patient?s own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
This report aims to provide a comprehensive presentation of the global market for Platelet-rich Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platelet-rich Plasma Therapy. This report contains market size and forecasts of Platelet-rich Plasma Therapy in global, including the following market information:
Global Platelet-rich Plasma Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Platelet-rich Plasma Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pure PRP Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Platelet-rich Plasma Therapy include Terumo, Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics and Weigao, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Platelet-rich Plasma Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Platelet-rich Plasma Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, by Type, 2022 (%)
Pure PRP
Leucocyte-rich PRP
Leukocyte-rich Fibrin (L-PRF)
Global Platelet-rich Plasma Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, by Application, 2022 (%)
Orthopedic
Darmatology
Cardiac Muscle Injury
Dental
Nerve Injury
Others
Global Platelet-rich Plasma Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Platelet-rich Plasma Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Platelet-rich Plasma Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Platelet-rich Plasma Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Terumo
Arthrex
Zimmer Biomet
DePuy Synthes
EmCyte
Regen Lab
ISTO Biologics
Cesca Therapeutics
Weigao
REV-MED
Nuo Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Platelet-rich Plasma Therapy, market overview.
Chapter 2: Global Platelet-rich Plasma Therapy market size in revenue.
Chapter 3: Detailed analysis of Platelet-rich Plasma Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Platelet-rich Plasma Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
